Monday, 19 December 2016

AstraZeneca oncology head jumps ship to become Innate CEO

LONDON (Reuters) - AstraZeneca is losing its head of oncology, Mondher Mahjoubi, who is departing to lead French biotech company Innate Pharma.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)